Analysis from the Randomized Phase 3 Aspire Trial - Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide & Dexamethasone - 101931

Spotlight
Video

Analysis from the Randomized Phase 3 Aspire Trial - Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide & Dexamethasone

ASHReport has 256 videos Subscribe Here

Loading........
Description: Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses the analysis from the randomized phase 3 Aspire trial and Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide & Dexamethasone at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/23/18
Added : 8 months ago
Category : Multiple Myeloma